Dr. Cleon R. Hubbard, MD

Dr. Hubbard practices at UPMC Harrisburg in Harrisburg, Pennsylvania.

Dr. Hubbard's NPI, 1043279946, was assigned on March 20, 2006. Dr. Hubbard holds Pennsylvania license MD422111.

Dr. Hubbard's primary practice is UPMC Harrisburg, at 111 S Front St, Harrisburg, PA 17101 in Dauphin County. The practice phone is (717) 230-3790.

Dr. Hubbard's primary practice is UPMC Harrisburg in Harrisburg, Pennsylvania. Dr. Hubbard is also affiliated with UPMC Harrisburg. The medical group on file is PinnacleHealth Cardiovascular Institute. Dmand AI also links Dr. Hubbard to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hubbard practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hubbard's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Hubbard is licensed in Pennsylvania.

CMS data shows 1,640 Medicare services from Dr. Hubbard across 25 procedure codes in 2024, for 1,021 Medicare patients. Medicare paid $79,661 for them.

CMS counts 1,021 Medicare patients who saw Dr. Hubbard in 2024. The largest group is 65 to 74, with 398 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hubbard's median patient age at 75, with 43% women.

In 2024, Dr. Hubbard wrote 4,958 Medicare Part D claims for 812 patients. 90% of them were for generic drugs. CMS names the drug for 4,647 of them, across 51 drugs with 11 or more claims each, at $518,776 in total drug cost. In 2023, CMS named 4,079 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hubbard for performance year 2024, reported as part of a group. Dr. Hubbard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of coronary angioplasty and stenting by Dr. Hubbard, more than 63% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Hubbard to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease, Foramen Ovale, Patent and Intermittent Claudication.

CMS Open Payments shows 140 general payments to Dr. Hubbard from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Medtronic Vascular, Inc. paid the most, $34,514.